The Chemours Company (NYSE:CC) Receives $26.75 Consensus Target Price from Brokerages

Shares of The Chemours Company (NYSE:CC – Get Free Report) have been given an average rating of “Hold” by the eight ratings firms that are covering the stock, MarketBeat.com reports. Five equities research analysts have rated the stock with a hold recommendation and three have assigned a buy recommendation to the company. The average 1 […]

Leave a Reply

Your email address will not be published.

Previous post Kymera Therapeutics, Inc. (NASDAQ:KYMR) Given Consensus Rating of “Moderate Buy” by Brokerages
Next post Match Group, Inc. (NASDAQ:MTCH) Given Average Recommendation of “Moderate Buy” by Brokerages